Evidence map›Paper›PMID 29470389›Full record

Trial reportNutrients2018

A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial.

Charlotte Bamberger, Andreas Rossmeier, Katharina Lechner, Liya Wu, Elisa Waldmann, Sandra Fischer, Renée G Stark, Julia Altenhofer, Kerstin Henze, Klaus G Parhofer

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06551285 (Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome), which is not on this map. Cited by 70 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 9 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06551285 narecruitingnot on this mapstarted 2024, after this paper: background citation

Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome

TypeinterventionalSponsorCelia BañulsRan2024 to 2029Enrolled120ConditionsPolycystic Ovary Syndrome, Metabolic SyndromeArmsOvapro (Lifepro)
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 9 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Review
  17. Food as Medicine for Hypertension: Microbiota as Mediators.Hypertension (Dallas, Tex. : 1979) · 2025
    Review
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Charlotte BambergerDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. charlotte.bamberger@med.uni-muenchen.de.
Andreas RossmeierDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. andreas.rossmeier@med.uni-muenchen.de.
Katharina LechnerDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. katharina.lechner@mri.tum.de.
Liya WuDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. wuliya@pennmedicine.upenn.edu.
Elisa WaldmannDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. elisa.waldmann@med.uni-muenchen.de.
Sandra FischerZIEL-Institute for Food & Health Core Facility, Technical University Munich, Weihenstephaner Berg 3, 85354 Freising, Germany. sandra.fischer@tum.de.
Renée G StarkHelmholtz-Zentrum Munich, Institute for Health Economics and Healthcare Management, 85764 Neuherberg, Germany. r.stark@helmholtz-muenchen.de.ORCID 0000-0002-6612-292X
Julia AltenhoferDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. julia.altenhofer@med.uni-muenchen.de.
Kerstin HenzeDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. kerstin.henze@med.uni-muenchen.de.
Klaus G ParhoferDepartment of Internal Medicine 4, Ludwig-Maximilians University Munich, Marchioninistraße 15, 81377 Munich, Germany. klaus.parhofer@med.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DEHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regular walnut consumption is associated with better health. We have previously shown that eight weeks of walnut consumption (43 g/day) significantly improves lipids in healthy subjects. In the same study, gut microbiome was evaluated. We included 194 healthy subjects (134 females, 63 ± 7 years, BMI 25.1 ± 4.0 kg/m²) in a randomized, controlled, prospective, cross-over study. Following a nut-free run-in period, subjects were randomized to two diet phases (eight weeks each); 96 subjects first followed a walnut-enriched diet (43 g/day) and then switched to a nut-free diet, while 98 subjects followed the diets in reverse order. While consuming the walnut-enriched diet, subjects were advised to either reduce fat or carbohydrates or both to account for the additional calories. Fecal samples were collected from 135 subjects at the end of the walnut-diet and the control-diet period for microbiome analyses. The 16S rRNA gene sequencing data was clustered with a 97% similarity into Operational Taxonomic Units (OTUs). UniFrac distances were used to determine diversity between groups. Differential abundance was evaluated using the Kruskal-Wallis rank sum test. All analyses were performed using Rhea. Generalized UniFrac distance shows that walnut consumption significantly affects microbiome composition and diversity. Multidimensional scaling (metric and non-metric) indicates dissimilarities of approximately 5% between walnut and control (

Indexed as

DietGastrointestinal MicrobiomeJuglansNutsWhite PeopleAgedBacteriaButyric AcidCross-Over StudiesFecesFemaleGastrointestinal TractGermanyHealthy VolunteersHumansMaleButyric AcidPrebioticsbutyric acidcholesteroldietgut microbiomelipidsnutsprebioticprobioticwalnuts

Identifiers

PMID29470389
PMCPMC5852820
OpenAlexW2793415967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.